- Report
- October 2024
- 194 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- September 2024
- 138 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2024
- 114 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- October 2024
- 184 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- April 2025
- 281 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 367 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- June 2023
- 58 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- October 2023
- 286 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- November 2023
- 190 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- December 2023
- 250 Pages
Global
€4546EUR$4,995USD£3,861GBP
- Report
- September 2023
- 146 Pages
Global
From €3211EUR$3,528USD£2,727GBP
€3777EUR$4,150USD£3,208GBP
- Report
- January 2022
- 242 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- January 2022
- 103 Pages
Europe
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 106 Pages
Asia Pacific
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 103 Pages
Middle East, Africa
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 93 Pages
North America
From €1365EUR$1,500USD£1,160GBP

The Human Enhancement market within the context of Biotechnology is a rapidly growing sector that focuses on the development of products and services that improve the physical and mental capabilities of humans. This includes the use of genetic engineering, nanotechnology, and other advanced technologies to enhance the human body and mind. Examples of Human Enhancement products and services include gene therapy, stem cell therapy, prosthetics, and cognitive enhancement drugs.
The Human Enhancement market is driven by the increasing demand for improved physical and mental performance, as well as the desire to extend life expectancy. This has led to a surge in investment in the sector, with many companies developing innovative products and services.
Some of the leading companies in the Human Enhancement market include Ginkgo Bioworks, CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics. These companies are focused on developing products and services that can improve the physical and mental capabilities of humans. Show Less Read more